[1] Pye M, Northcote R J, Cobbe S M. Acute hepatitis parenteral amiodarone administration[J]. Br Heart J, 1988, 59: 690-691.
[2] 李崇剑,周宪粱,张沛,等.静脉用胺碘酮致严重肝功能损害一例[J].中华心律失常学杂志,2004,8(4)：251.
[3] Lahbabi M, Aqodad N,Ibrahimi A, et al. Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy[J].World J Hepatol, 2012, 4(6): 196-198.
[4] 吕栋,赵敏.静脉滴注莫西沙星致急性肝损伤[J]. 药物不良反应杂志, 2012, 14(6): 391-392.
[5] Franco Hidalgo S, Prieto de Paula J M, García Lorenzo R, et al.Moxifloxacin and hepatic toxicity[J].Gastroenterol Hepatol, 2009,32(10): 719-720.
[6] 黄丽贞,雷光远,雷招宝. 莫西沙星致肝损害16 例文献分析[J].药物流行病学杂志, 2012, 21(12): 631-633.
[7] Prescott L F. Hepatotoxicity of mild analgesics[J]. Br J Clin Pharmacol,1980, 2: 373S-379S.
[8] Rhodes A, Eastwood J B, Smith S A. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle[J].Gut, 1993,34(4):565-566.
[9] Chan A L, Hsieh H J, Hsieh Y A,et al. Fatal amiodarone-induced hepatotoxicity: a case report and literature review[J]. Int J Clin Pharmacol Ther, 2008, 46: 96-101.
[10] Munoz A, Karila P, Gallay P, et a1.A randomized hemodynamic comparison of intravenous amiodar one with and with out Tween80[J].Eur Heart J, 1988, 9(2): 142-148.
[11] 温伟,纪立伟,张新超.胺碘酮静脉滴注致急性肝损伤15 例临床分析[J].药物不良反应杂志, 2006,8(2)：105-109.
[12] Tisdale J E, Follin S L, Ordelova A, et a1．Risk factors fot the development of specific noncardiovascular adverse efects associated with amiodarone[J]. J Clin Pharmacol, 1995, 35(4): 351-356.
[13] 中国生物医学工程学会心律分会,中华医学会心血管病学分会,胺碘酮抗心律失常治疗应用指南工作组.胺碘酮抗心律失常治疗应用指南[J].中国心脏起博与心电生理杂志, 2008,22（5）：377-385. |
